Having involuntarily adjusted my personal policy in my dealings with FitRx/Zealthy, perhaps they, too, could make an exception
GPs should keep in mind the stopping rule for the 3 mg liraglutide product for obesity: treatment should be discontinued after 12 weeks on the maximum 3 mg daily dose if the patient has not lost at least 5% of their body weight
Compounding advocates say that, although the drugs are not FDA-approved, they are still subject to rigorous quality control, in part due to post-2012 rule changes
Through WeightWatchers holistic weight health model, which pairs medication access with a clinically proven nutrition-based program, lifestyle change, and community support, members receive care that can improve and extend adherence and minimize side effects of weight management medications, ultimately driving more sustainable and superior results